Figure 2. Anti-CD3 therapy attenuates autoantibody production in SLE mice.
Circulating anti-dsDNA autoantibodies (presented as antibody activity index) measured in control and SLE mice administered anti-IgG or anti-CD3 (n = 3–12).
Circulating anti-dsDNA autoantibodies (presented as antibody activity index) measured in control and SLE mice administered anti-IgG or anti-CD3 (n = 3–12).